TABLE 1.
Modification type | Modification site | Enzyme | Effect on Pin1 | References |
Phosphorylation | S16 | PKA | Inhibit binding ability and nuclear localization | Lu et al., 2002 |
Phosphorylation | S16 | Aurora A | Inhibit binding ability | Lee et al., 2013 |
Phosphorylation | S16 | RSK2 | Increase binding ability | Cho et al., 2012 |
Phosphorylation | S16 | COT | Increase binding ability | Kim et al., 2015 |
Phosphorylation | S71 | DAPK1 | Inhibit catalytic activity and nuclear localization | Lee et al., 2011a; Kim et al., 2014; Mahoney et al., 2018 |
Phosphorylation | S138 | MLK3 | Increase catalytic activity and nuclear translocation | Rangasamy et al., 2012 |
Phosphorylation | S65 | Plk1 | Inhibit ubiquitination and increase protein stability | Eckerdt et al., 2005 |
SUMOylation | K6, K63 | SUMO1 | Inhibit binding ability and catalytic activity | Chen et al., 2013 |
Oxidation | C113 | Inhibit catalytic activity and nuclear localization | Chen et al., 2015 | |
Oxidation | M130, M146 | Unknown | Ando et al., 2013 | |
Acetylation | K46 | Unknown | Choudhary et al., 2009; Ando et al., 2013 |
PKA, cAMP-protein kinase A; RSK2, ribosomal protein S6 kinase 2; DAPK1, death-associated protein kinase 1; MLK3, mixed-lineage kinase 3; Plk1, polo-like kinase 1; SUMO1, small ubiquitin-like modifier 1.